Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The DIAMET Study
NCT00169624Phase 3Terminated
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in endothelial dysfunction (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Flow dependent and independent Brachial artery vasoreactivity at 3 months. Started Oct 2005; status: terminated.
02
Drugs
metformin
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT00169624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169624.